What’s Happening With Alnylam Stock?

What’s Happening With Alnylam Stock?

The stock price of Alnylam Pharmaceuticals, a pharmaceutical company focused on RNA interference therapeutics for genetically defined diseases, plunged over 15% in yesterday’s trading session, following its Q3 results, which were much lower than the Wall Street estimates. The company reported…